Tumor Regression and Allograft Rejection after Administration of Anti–PD-1
- 3 March 2016
- journal article
- letter
- Published by Massachusetts Medical Society in The New England Journal of Medicine
- Vol. 374 (9), 896-898
- https://doi.org/10.1056/nejmc1509268
Abstract
Cancers, especially skin cancers, may develop in patients undergoing solid-organ transplantation who receive long-term immunosuppression. The use of anti–PD-1 in one such patient produced an antitumor response but led to rejection of the transplanted kidney.Keywords
This publication has 4 references indexed in Scilit:
- Antagonists of PD-1 and PD-L1 in Cancer TreatmentSeminars in Oncology, 2015
- Identification and management of toxicities from immune checkpoint-blocking drugs.2014
- Successful Administration of Ipilimumab to Two Kidney Transplantation Patients With Metastatic MelanomaJournal of Clinical Oncology, 2014
- Distant metastases from cutaneous squamous cell carcinoma—analysis of AJCC stage IVHead & Neck, 2012